John W. Kozarich, a director at Ligand Pharmaceuticals ($LGND), sold shares on the open market 36 times over the past year, totaling about $792,000. His most recent sale occurred on March 2, 2026. These transactions rank him 5,432nd out of 11,678 insiders by sale value, below the average of $8.6 million across 6.4 transactions per insider. Kozarich made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 146 | $199.97 | 42,574.0000 | 20,629,000 | 0.34% | 0.00% |
| April 1, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 43 | $202.91 | 42,412.0000 | 20,629,000 | 0.10% | 0.00% |
| April 1, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 79 | $202.42 | 42,455.0000 | 20,629,000 | 0.19% | 0.00% |
| April 1, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 159 | $204.26 | 42,253.0000 | 20,629,000 | 0.37% | 0.00% |
| April 1, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 40 | $201.24 | 42,534.0000 | 20,629,000 | 0.09% | 0.00% |
| March 2, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 204 | $199.69 | 42,936.0000 | 20,629,000 | 0.47% | 0.00% |
| March 2, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 42 | $203.57 | 42,720.0000 | 20,629,000 | 0.10% | 0.00% |
| March 2, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 50 | $202.54 | 42,762.0000 | 20,629,000 | 0.12% | 0.00% |
| March 2, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 83 | $201.65 | 42,812.0000 | 20,629,000 | 0.19% | 0.00% |
| March 2, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 41 | $200.40 | 42,895.0000 | 20,629,000 | 0.10% | 0.00% |
| March 2, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 47 | $197.14 | 43,140.0000 | 20,629,000 | 0.11% | 0.00% |
| Feb. 2, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 39 | $191.00 | 43,615.0000 | 20,629,000 | 0.09% | 0.00% |
| Feb. 2, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 23 | $197.20 | 43,187.0000 | 20,629,000 | 0.05% | 0.00% |
| Feb. 2, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 381 | $196.36 | 43,210.0000 | 20,629,000 | 0.87% | 0.00% |
| Feb. 2, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 23 | $195.61 | 43,591.0000 | 20,629,000 | 0.05% | 0.00% |
| Feb. 2, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 1 | $192.18 | 43,614.0000 | 20,629,000 | 0.00% | 0.00% |
| Jan. 2, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 21 | $186.59 | 44,100.0000 | 20,629,000 | 0.05% | 0.00% |
| Jan. 2, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 46 | $192.40 | 43,654.0000 | 20,629,000 | 0.11% | 0.00% |
| Jan. 2, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 207 | $190.27 | 43,700.0000 | 20,629,000 | 0.47% | 0.00% |
| Jan. 2, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 102 | $188.96 | 43,907.0000 | 20,629,000 | 0.23% | 0.00% |
| Jan. 2, 2026 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 91 | $187.95 | 44,009.0000 | 20,629,000 | 0.21% | 0.00% |
| Dec. 1, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 4 | $196.35 | 44,266.0000 | 20,629,000 | 0.01% | 0.00% |
| Dec. 1, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 92 | $193.86 | 44,496.0000 | 20,629,000 | 0.21% | 0.00% |
| Dec. 1, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 179 | $194.76 | 44,317.0000 | 20,629,000 | 0.40% | 0.00% |
| Dec. 1, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 47 | $195.80 | 44,270.0000 | 20,629,000 | 0.11% | 0.00% |
| Dec. 1, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 92 | $197.72 | 44,174.0000 | 20,629,000 | 0.21% | 0.00% |
| Dec. 1, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 23 | $199.22 | 44,151.0000 | 20,629,000 | 0.05% | 0.00% |
| Dec. 1, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 30 | $200.02 | 44,121.0000 | 20,629,000 | 0.07% | 0.00% |
| Nov. 3, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 84 | $189.00 | 44,971.0000 | 20,629,000 | 0.19% | 0.00% |
| Nov. 3, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 127 | $192.38 | 44,588.0000 | 20,629,000 | 0.28% | 0.00% |
| Nov. 3, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 207 | $191.25 | 44,715.0000 | 20,629,000 | 0.46% | 0.00% |
| Nov. 3, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 49 | $190.26 | 44,922.0000 | 20,629,000 | 0.11% | 0.00% |
| Oct. 1, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 196 | $178.41 | 45,302.0000 | 20,629,000 | 0.43% | 0.00% |
| Oct. 1, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 92 | $181.18 | 45,055.0000 | 20,629,000 | 0.20% | 0.00% |
| Oct. 1, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 155 | $180.01 | 45,147.0000 | 20,629,000 | 0.34% | 0.00% |
| Oct. 1, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 24 | $177.60 | 45,498.0000 | 20,629,000 | 0.05% | 0.00% |
| Sept. 2, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 115 | $162.52 | 45,607.0000 | 18,290,000 | 0.25% | 0.00% |
| Sept. 2, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 85 | $164.25 | 45,522.0000 | 18,290,000 | 0.19% | 0.00% |
| Sept. 2, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 267 | $161.51 | 45,722.0000 | 18,290,000 | 0.58% | 0.00% |
| Aug. 1, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 467 | $131.88 | 45,989.0000 | 18,290,000 | 1.01% | 0.00% |
| July 10, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | S | Common Stock | 934 | $125.00 | 46,456.0000 | 18,290,000 | 1.97% | 0.01% |
| June 6, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | A | Non-Qualified Stock Option (right to buy) | 5783 | $0.00 | 5,783.0000 | 18,290,000 | 9999.99% | 0.03% |
| June 6, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | A | Common Stock | 1209 | $0.00 | 47,390.0000 | 18,290,000 | 2.62% | 0.01% |
| Jan. 17, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | M | Non-Qualified Stock Option (right to buy) | 2406 | $0.00 | 0.0000 | 18,290,000 | 100.00% | 0.01% |
| Jan. 17, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | M | Common Stock | 2406 | $52.30 | 46,181.0000 | 18,290,000 | 5.50% | 0.01% |
| June 14, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | A | Common Stock | 1252 | $0.00 | 43,775.0000 | 17,757,000 | 2.94% | 0.01% |
| June 14, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | A | Non-Qualified Stock Option (right to buy) | 5444 | $0.00 | 5,444.0000 | 17,757,000 | 9999.99% | 0.03% |
| April 24, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | M | Common Stock | 2893 | $39.35 | 42,523.0000 | 17,757,000 | 7.30% | 0.02% |
| April 24, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | KOZARICH JOHN W | Director | M | Non-Qualified Stock Option (right to buy) | 2893 | $0.00 | 0.0000 | 17,757,000 | 100.00% | 0.02% |